From Newsday.com: Affiliations of UMDNJ board members come under scrutiny. A snip...

Interesting editorial in the New York Times about what healthcare can learn from manufacturing organizations that will help to cut down on medical mistakes through improving processes.

Stung by Public Distrust, Drug Makers Seek to Heal Image: "'The decision against Merck...is a clear statement that despite all the good our industry is doing, we're losing the battle for consumer trust,' says Arthur Higgins, chairman of Bayer...

According to the Wall St. Journal, the National Institutes of Health has decided to ease some of the restrictions it put in place earlier this year, including easing its rules on stock ownership...

A message from the Alliance for CME...

After reading this New York Times article, I can't help but wonder: Age-Old Cures, Like the Maggot, Get U.S. Hearing.

From the Wall Street Journal (free access for seven days): Reading Fine Print, Insurers Question Studies of Drugs: Kaiser's Veteran Sleuth Scours Medical-Journal Articles And Sees Marketing Spin. A snip...

Here's another post courtesy of Anne Taylor-Vaisey...

Here's another post courtesy of Anne Taylor-Vaisey...

This post courtesy of Anne Taylor-Vaisey...